Tuberous Sclerosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions:   Tuberous Sclerosis Complex;   Seizures, FocalIntervention:   Drug: GWP42003-PSponsor:   GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions:   Tuberous Sclerosis Complex;   Seizures, FocalInterventions:   Drug: GWP42003-P;   Drug: PlaceboSponsor:   GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions:   Tuberous Sclerosis Complex;   Seizures, FocalIntervention:   Drug: GWP42003-PSponsor:   GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Focal Seizures in Tuberous Sclerosis Complex.
Conditions:   Tuberous Sclerosis Complex;   Seizures, FocalInterventions:   Drug: GWP42003-P;   Drug: PlaceboSponsor:   GW Research LtdNot yet recruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2015 Category: Research Source Type: clinical trials